In solid tumors, Schoutrop et al. reported that CAR-T cells that target mesothelin (MSLN) also depleted MSLN in human ovarian cancer cells via trogocytosis, which led to target antigen loss80. The gene discussed is MSLN; the disease is ovarian cancer.